PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UC Davis MIND Institute researchers identify specific fetal antigens attacked by maternal antibodies

Researchers identify risk factor for autism in a subset of children: Maternal antibody-related autism

2013-07-09
(Press-News.org) UC Davis MIND Institute researchers have identified the specific antibodies that target fetal brain proteins in the blood of a subset of women whose children are diagnosed with autism. The finding is the first to pinpoint a specific risk factor for a significant subset of autism cases, as well as a biomarker for drug development and early diagnosis. The researchers have named autism related to these antibodies "Maternal Autoantibody-Related," or MAR autism.

The study found that the mothers of children with autism were more than 21 times as likely to have the specific MAR antibodies in their systems that reacted with fetal brain proteins, or antigens, than were the mothers of children who did not have autism. In fact, specific combinations of MAR antibodies were not found in the blood of mothers whose children were typically developing.

The research, "Autism-specific maternal autoantibodies recognize critical proteins in developing brain," is published online today in Translational Psychiatry, a Nature journal.

The study was led by principal investigator and immunologist Judy Van de Water, a researcher affiliated with the MIND Institute. Earlier studies by Van de Water and her colleagues found that women with certain antibodies in their bloodstreams are at greater risk of having a child with autism and that their children exhibited more severe language delays, irritability and self-injurious behaviors than did the autistic children of mothers whose blood did not have the antibodies.

"Now we will be able to better determine the role of each protein in brain development," said Van de Water, professor of internal medicine. "We hope that, one day, we can tell a mother more precisely what her antibody profile means for her child, then target interventions more effectively."

To identify the exact antigens targeted by the mothers' antibodies, Van de Water and her colleagues conducted the research in Northern California using blood samples from 246 mothers of children with autism and of a control group of 149 mothers of children without autism to examine their reactivity with the candidate antigens.

Seven antigens were significantly more reactive to the blood of mothers of children with autism than to that of the control mothers. The study found that the mothers with antibodies that reacted with any one of these antigens, either individually or in combination with other antigens, were more than three times as likely to have a child with autism spectrum disorder.

Several combinations of antibodies in the blood from mothers of children with autism were not found in the control mothers' blood. Nearly 23 percent of mothers of children with autism had certain combinations of autoantibodies against the target antigens, compared with less than 1 percent of mothers of children without the disorder.

VIDEO: Judy Van de Water, MIND Institute, discusses her maternal antibody-related autism research
Click here for more information.

The specific antigens identified in the study are lactate dehydrogenase A and B, cypin (guanine deaminase), stress-induced phosphoprotein 1, collapsing response mediator proteins 1 and 2, and Y-box binding protein. All are found throughout the body, but also are expressed at significant levels in the human fetal brain and have established roles in neurodevelopment. For example, cypin is an enzyme that plays an important role in normal neurite branching, a fundamental function in the developing brain, whereas the CRMP proteins are critical later in neuron development for axon outgrowth.

Maternal antibodies are known to cross the placenta during pregnancy and can be detected in a fetus as early as 13 weeks. By 30 weeks, maternal antibody levels in the fetus are about half that of the mother, and at birth, the concentration is even greater in the newborn than in the mother herself. The maternal antibodies stay in the baby's bloodstream for about 6 months after birth, after which the baby's own immune system takes over.

Once in the fetal bloodstream, the antibodies then may enter the brain and attack cells that have corresponding proteins that act as antigens. This antigen-antibody response is an important defense against foreign invaders, such as bacteria or viruses, but is not normally directed against oneself. When directed against one's own tissue, the antibodies are known as autoantibodies.

"It is important to note that women have no control over whether or not they develop these autoantibodies, much like any other autoimmune disorder," Van de Water said. "And, like other autoimmune disorders, we do not know what the initial trigger is that leads to their production."

Understanding which proteins and which pathways are implicated in MAR autism can help elucidate the causes of autism and possibly lead to new therapies, such as administering 'antibody blockers' to the mother during pregnancy to prevent damage to the developing fetal brain, Van de Water said.

These findings are leading to the development of a MAR diagnostic test for autism, which would be available to the mothers of young children who are showing signs of developmental delay. If the test were positive, the child would be a candidate for early behavioral intervention.

"These findings are incredibly important because they establish a cause for a significant portion of autism cases, thereby opening up new lines of inquiry into possible biological treatments," said MIND Institute Director Leonard Abbeduto. "In addition, the findings demonstrate that a diagnostic test is within reach. This test would be invaluable for women who are considering becoming pregnant and could lead to earlier and more accurate diagnosis of children with developmental challenges and help get them into behavioral interventions at younger ages."

A MAR diagnostic test also would assess a mother's risk of having a child with autism prior to conception, which is particularly important for women who already have a child with the disorder. UC Davis has patented this technology and licensed the exclusive worldwide rights to develop it for commercial purposes to Pediatric Bioscience, Inc.

"We know that early behavioral interventions for autism are critical," said Isaac Pessah, professor and chair of the Department of Molecular Biosciences in the UC Davis School of Veterinary Medicine and former director of the UC Davis Center for Children's Environmental Health. "Developing a predictive test for autism before symptoms become obvious could have an enormous impact on treating children with the condition."

Study participants were from the CHARGE (Childhood Autism Risks from Genetics and the Environment) study, an ongoing study that was launched in 2001 by the MIND Institute and the UC Davis Center for Children's Environmental Health, of which Van de Water now is director. Children with autism spectrum disorder, children with developmental delay and typically developing children between the ages of 2 and 5 years are studied with the goal of better understanding the causes of autism.

A related study is the MARBLES (Markers of Autism Risk in Babies ― Learning Early Signs) study, also being conducted at the MIND Institute and the Center for Children's Environmental Health. This study follows pregnant women who already have a child with autism. Multiple factors related to genetics and the environment is under study in an effort to uncover predictors for having a child with autism.

Van de Water said knowing the specific protein targets of the maternal antibodies enables researchers to develop more precise animal models of autism.



INFORMATION:



The study was funded by NIEHS grants P01 ES11269-01 and 1 R01-ES015359; United States Environmental Protection Agency Science to Achieve Results (STAR) program grant R829388; the UC Davis MIND Institute; and an Autism Speaks graduate fellowship.

Other authors include Daniel Braunschweig, Paula Krakowiak, Paul Duncanson, Robert Boyce, Robin Hansen, Paul Ashwood and Irva Hertz-Picciotto, all of UC Davis.

At the UC Davis MIND Institute, world-renowned scientists engage in collaborative, interdisciplinary research to find the causes of and develop treatments and cures for autism, attention-deficit/hyperactivity disorder (ADHD), fragile X syndrome, 22q11.2 deletion syndrome, Down syndrome and other neurodevelopmental disorders. For more information, visit mindinstitute.ucdavis.edu



ELSE PRESS RELEASES FROM THIS DATE:

UC Davis MIND Institute researchers find exposure to maternal antibodies affects behavior

2013-07-09
Researchers with the UC Davis MIND Institute have found that prenatal exposure to specific combinations of antibodies found only in mothers of children with autism leads to changes in the brain that adversely affect behavior and development. The researchers said that the highly specific immunoglobulin-G (IgG) autoantibodies cross the placenta during pregnancy to impact fetal brain development, resulting in a form of autism that the researchers now are calling maternal antibody-related (MAR) autism. The researchers said that MAR autism cases could represent as much as ...

Parasites in cat poop: Potential public health problem?

2013-07-09
Each year in the United States, cats deposit about 1.2 million metric tons of feces into the environment, and that poop is carrying with it what may be a vast and underappreciated public health problem, say scientists July 9 in the journal Trends in Parasitology, a Cell Press publication. Some of that poop is laden with an infectious parasite known as Toxoplasma gondii, a protozoan that has recently caused toxoplasmosis epidemics in otherwise healthy people, not just in pregnant women or people with immune deficiencies. Additional concerns have been raised by studies ...

Health info exchange: Short-term growth, but long-term concerns

2013-07-09
ANN ARBOR –While record numbers of hospitals and doctors participate in electronic health information exchange efforts, which enable medical histories to follow patients as they move between healthcare providers, the long-term success of these programs is in question. That's according to a new national survey of health information exchange organizations led by a University of Michigan researcher. Health information exchange efforts come into play primarily when patients switch doctors or are admitted to a hospital. Because they give doctors access to patients' medical ...

Women who give birth to multiple babies after IVF are at higher risk of breast cancer

2013-07-09
London -- Women who give birth to multiple babies following IVF treatment are at a higher risk of breast cancer than those giving birth to singletons or who remain childless. Dutch investigators from the Omega study group said the explanation may not be the multiple pregnancy per se but a maternal trait related to a higher implantation potential and to breast cancer itself. Although the results were derived from a large nationwide cohort study, the investigators emphasise that the findings should next be replicated in further studies and that presently there is no reason ...

Female obesity linked to lower rates of live birth and embryo implantation in the uterus

2013-07-09
London, 9 July 2013: An analysis of almost 10,000 first cycles of egg donation treatment at one of Europe's largest IVF centres shows that female obesity reduces the receptivity of the uterus to embryo implantation and thereby compromises reproductive outcome. The investigators report that excess female weight "impairs human reproduction" and that "the reduction of uterine receptivity is one of the mechanisms involved". As a result they advise weight reduction before pregnancy in any type of conception, including ovum donation. The study is presented today at the ...

Large UK population study finds no increased cancer risk in children born after assisted conception

2013-07-09
London, 9 July 2013: Children born as a result of assisted reproduction (ART) are at no greater risk of cancer than children born spontaneously in the general population, according to results of one of the largest ever cohort studies of ART children. "This is reassuring news for couples considering assisted conception, their subsequent children, fertility specialists and for the wider public health," said the investigators. Results of the study were presented today at the annual meeting of ESHRE by Dr Carrie Williams from the Institute of Child Health, University ...

Women working shifts are at greater risk of miscarriage, menstrual disruption and subfertility

2013-07-09
London, 9 July 2013: Shift work, which encourages sleep deprivation and patterns of activity outside the circadian rhythm, has been associated with a greater risk of ill health and loss of well-being in some (but not all) studies.(1) However, little is known about the effects of shift work on reproductive health and fertility. Now, a study reported today at the annual meeting of ESHRE, by Dr Linden Stocker from the University of Southampton, UK, indicates that working shift patterns is associated with an increased risk of menstrual disruption and subfertility. The ...

Egg banking for social reasons

2013-07-09
London, 9 July 2013: Egg freezing as insurance against age-related infertility is a growing trend in many countries. Women who bank oocytes for use at some time in the future hope to buy a little time in their search for a suitable partner. However, a study from one of Europe's largest centres in reproductive medicine suggests that many of those banking eggs believe they will never use them - even though they still recognise the experience as "positive". The majority of those who did (and did not) freeze their eggs wished they had done so at an earlier age. The study ...

Research demonstrates the influence of temporal niches in maintaining biodiversity

2013-07-09
By studying rapidly evolving bacteria as they diversify and compete under varying environmental conditions, researchers have shown that temporal niches are important to maintaining biodiversity in natural systems. The research is believed to be the first experimental demonstration of temporal niche dynamics promoting biodiversity over evolutionary time scales. The temporal niches – changes in environmental conditions that occur during specific periods of time – promoted frequency-dependent selection within the bacterial communities and positive growth of new mutants. ...

Tumor-suppressor Protein Gives Up Its Secrets

2013-07-09
Genetic mutations aren't the only thing that can keep a protein called PTEN from doing its tumor-suppressing job. Johns Hopkins researchers have now discovered that four small chemical tags attached (reversibly) to the protein's tail can have the same effect, and they say their finding may offer a novel path for drug design to keep PTEN working. In a report published on July 9 in the journal eLife, the Johns Hopkins scientists describe how a cluster of four phosphate groups, first found 13 years ago to bind to PTEN's tail, controls its activity. "Now that we know ...

LAST 30 PRESS RELEASES:

Dicamba drift: New use of an old herbicide disrupts pollinators

Merging schools to reduce segregation

Ending pandemics with smartwatches

Mapping consensus locations for offshore wind

Breakthrough in clean energy: Palladium nanosheets pave way for affordable hydrogen

Novel stem cell therapy repairs irreversible corneal damage in clinical trial

News article or big oil ad? As native advertisements mislead readers on climate change, Boston University experts identify interventions

Advanced genetic blueprint could unlock precision medicine

Study: World’s critical food crops at imminent risk from rising temperatures

Chemistry: Triple bond formed between boron and carbon for the first time

How a broken bone from arm wrestling led to a paradigm shift in mental health: Exercise as a first-line treatment for depression

Alarming levels of microplastics discovered in human brain tissue, linked to dementia

Global neurology leader makes The Neuro world's first open science institute

Alpha particle therapy emerges as a potent weapon against neuroendocrine tumours

Neuroscience beyond boundaries: Dr. Melissa Perreault bridges Indigenous knowledge and brain science

Giant clone of seaweed in the Baltic Sea

Motion capture: In world 1st, M. mobile’s motility apparatus clarified

One-third of older Canadians at nutritional risk, study finds

Enhancing climate action: satellite insights into fossil fuel CO2 emissions

Operating a virtual teaching and research section as an open source community: Practice and experience

Lack of medical oxygen affects millions

Business School celebrates triple crown

Can Rhizobium + low P increase the yield of common bean in Ethiopia?

Research Security Symposium on March 12

Special type of fat tissue could promote healthful longevity and help maintain exercise capacity in aging

Researchers develop high-water-soluble pyrene tetraone derivative to boost energy density of aqueous organic flow batteries

Who gets the lion’s share? HKU ecologists highlight disparities in global biodiversity conservation funding

HKU researchers unveil neuromorphic exposure control system to improve machine vision in extreme lighting environments

Researchers develop highly robust, reconfigurable, and mechanochromic cellulose photonic hydrogels

Researchers develop new in-cell ultraviolet photodissociation top-down mass spectrometry method

[Press-News.org] UC Davis MIND Institute researchers identify specific fetal antigens attacked by maternal antibodies
Researchers identify risk factor for autism in a subset of children: Maternal antibody-related autism